AMPLY
To add a bio or update company history, please click update information.
News from AMPLY
AMPLY
11 Feb 2026
AMPLY Discovery secures strategic investment from Keeps Biomed for its AI-led oncology drug discovery solution
AMPLY Discovery applies AI to identify and validate new oncology drug targets. It combines computational analysis with laboratory testing to generate therapeutic programmes for partnering.
AMPLY
1 May 2025
AMPLY raises £1.3m seed led by Twin Path Ventures to accelerate drug discovery for aggressive cancers and superbugs
AMPLY builds an AI driven drug discovery platform that combines computational biology, sequencing and lab validation to develop new treatments for aggressive cancers and drug resistant infections.
AMPLY
- Life Sciences
- Belfast, United Kingdom
- amplydiscovery.com
- Update Information
More venture news
- 5 Aug 2026
MironidMironid raises a £34m Series B including £8.4m from Scottish National Investment Bank to advance small molecule treatments for kidney diseases
Series BLife Sciences - 29 Jul 2026
QureightQureight lands £15m Series B led by Molten Ventures to bring AI imaging to clinical trials for lung and heart disease
Series BLife Sciences - 7 Jul 2026
Healome TherapeuticsHealome Therapeutics raises £2m to advance eye-drop matrix technology treating dry eye and ocular surface disease
SeedLife Sciences